5-Aminolevulinic acid-mediated photodynamic activity in patient-derived cholangiocarcinoma organoids

Surg Oncol. 2020 Dec:35:484-490. doi: 10.1016/j.suronc.2020.10.011. Epub 2020 Oct 21.

Abstract

Background: Accurate diagnosis of the disease extension of cholangiocarcinoma (CCA) is often difficult in clinical practice. The diagnostic yield of conventional pre-operative imaging or endoscopic procedures is sometimes insufficient for the evaluation of longitudinal spreading of CCA. Here we investigated the usefulness of 5-aminolevulinic acid (5-ALA) for the pre- or intra-operative diagnosis of CCA, using patient-derived organoids.

Methods: Four CCA- and two adjacent tissue-derived organoids were established. After 5-ALA treatment, we assessed their photodynamic activity using fluorescence microscopy.

Results: CCA organoids established from different patients showed diverse morphology in contrast to monolayer structures of non-tumor organoids, and had the ability to form subcutaneous tumors in immunodeficient mice. CCA organoids demonstrated remarkably high photodynamic activity based on higher accumulation of protoporphyrin IX as a metabolite of 5-ALA compared to non-tumor organoids (40-71% vs. < 4%, respectively). Importantly, cancer cell-specific high photodynamic activity distinguished the organoids originated from biliary stenotic lesions from those of non-stenotic lesions in a CCA patient. The high photodynamic activity did not depend on the expression profile of heme biosynthesis genes.

Conclusions: Distinct 5-ALA-based photodynamic activity could have diagnostic potential for the discrimination of CCA from non-tumor tissues.

Keywords: 5-Aminolevulinic acid; Cholangiocarcinoma; Organoid.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aminolevulinic Acid
  • Animals
  • Bile Duct Neoplasms / drug therapy*
  • Bile Duct Neoplasms / metabolism
  • Bile Duct Neoplasms / pathology
  • Cholangiocarcinoma / drug therapy*
  • Cholangiocarcinoma / metabolism
  • Cholangiocarcinoma / pathology
  • Female
  • Follow-Up Studies
  • Humans
  • Levulinic Acids / pharmacology*
  • Male
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Middle Aged
  • Organoids / drug effects*
  • Organoids / metabolism
  • Organoids / pathology
  • Photochemotherapy / methods*
  • Prognosis
  • Protoporphyrins / analysis
  • Protoporphyrins / metabolism*
  • Xenograft Model Antitumor Assays

Substances

  • Levulinic Acids
  • Protoporphyrins
  • protoporphyrin IX